Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung Cancer
QOD SBRT schedules were more frequently used to treat stage I NSCLC than daily regimens by a factor of 3:1, and QOD 5-fraction SBRT became the most common dose schedule after 2012. Three-fraction QOD SBRT was associated with improved survival versus daily, whereas 5-fraction QOD SBRT was associated with worse survival versus daily.
Authors
- Yue Lin (ORCID: https://orcid.org/0000-0003-4143-174X)
- Kimberley S. Mak (ORCID: https://orcid.org/0000-0002-7388-5124)
- Minh Tam Truong (ORCID: https://orcid.org/0000-0001-6662-4981)
- Sonny Batra
- Muhammad M. Qureshi (ORCID: https://orcid.org/0000-0002-2056-3308)
Institutions
- Boston University (US)
- Boston Medical Center (US)
- VA Boston Healthcare System (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.adro.2024.101625
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42